Hypertension is the most common preventable risk factor for CVDs (including coronary heart disease, heart failure, stroke, myocardial infarction, atrial fibrillation, and peripheral artery disease), chronic kidney disease, and cognitive impairment, and also the main single factor for deaths and disability worldwide (133)
Muscle Loss Risk Increases (Major Concern) GLP-1 users already risk: low protein intake low calorie intake rapid weight loss lean tissue loss Add nightly alcohol and you get: impaired muscle protein synthesis lower testosterone (men) reduced growth hormone increased cortisol reduced recovery Result: More muscle loss Less fat loss Softer look Slower metabolism This is one of the biggest physiological downsides
Compounded Tirzepatide (GLP-1+GIP): Omzo describes tirzepatide as a dual-hormone approach targeting appetite, blood sugar, and metabolism
The SURPASS clinical trial program showed mean heart rate increases of approximately 2 to 4 beats per minute
The exact dose varies from person to person and should always be determined by a healthcare provider
My content has noticeably shifted from weight loss to weight maintenance and yall have had questions